Cosmetics Reg Reform Ill-Situated As Trump, FDA Explore 'Burden Reduction'
This article was originally published in The Rose Sheet
Executive Summary
Any movement to advance proposed cosmetics reform legislation could be seen as running counter to President Trump's executive orders earlier this year, which now have FDA centers seeking "broad public comment" on how to achieve "meaningful burden reduction."